The Valley Desk

ArticleTransplantation and cellular therapyPublished

Cis-targeted IL-2 Mutein to Augment the Antitumor Activity of Engineered T Cells

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Transplantation and cellular therapy
Published
Subject terms
T-Lymphocytes; Animals; Humans; Mice; Interleukin-2; Immunotherapy, Adoptive; Adoptive Cell Therapy; Car T Cells; Cytokine Engineering; T-cell Persistence; Egfrt; Cis-targeted Il-2
PubMed ID
42532276
Added to directory
Source checked

Report a correction or request removal